Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sanofi-Aventis Asia Pacific R&D Head Frank Jiang On Opportunities In China And India: An Interview With PharmAsia News (Part 2 of 2)

This article was originally published in PharmAsia News

Executive Summary

Sanofi-Aventis VPand Head, Asia PacificR&D Frank Jiang talked to PharmAsia News along the sidelines of the recent DIA China conference in Beijing. Jiang shared his vision of how the company is revamping its R&D strategies in Asia to bring more therapies to patients in India and China.

You may also be interested in...



Sanofi-Aventis Asia Pacific R&D Head Frank Jiang On Opportunities In China And India: An Interview With PharmAsia News (Part 1 of 2)

Sanofi-Aventis VPand Head, Asia PacificR&D Frank Jiang talked to PharmAsia News along the sidelines of the recent DIA China conference in Beijing. Jiang shared his vision of how the company is revamping its R&D strategies in Asia to bring more therapies to patients in India and China.

China At Ground Zero In Explosion of New Diabetes Cases; International Federation Now Projects 500 Million Diabetics Worldwide By 2030

BEIJING - A vast new study conducted by scientists in North America and Asia places China at ground zero in terms of an explosion in the incidence of diabetes, and "shows that the global burden of diabetes is far larger than previously estimated," according to a scholar at the Brussels, Belgium-based International Diabetes Federation

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

UsernamePublicRestriction

Register

LL1135424

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel